Preclinical studies represent the an important stage in the drug development and introduction into clinical practice. They allow to evaluate pharmacological, toxicological and pharmaceutical properties of the developed product. Preclinical studies comprise a significant part of the registration dossier prepared for regulatory approval of a pharmaceutical product. Results of preclinical studies are filed with a clinical trial protocol and draft instructions for use. On the basis of these results, the researchers decide on the launch of clinical trials.
Please see below a list of preclinical study types performed by the labs of National BioService: